GNG12 regulates PD‐L1 expression by activating NF‐κB signaling in pancreatic ductal adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive solid tumors in the digestive system. A greater understanding of the pathogenesis of PDAC may facilitate the search for new therapeutic targets. Guanine nucleotide‐binding protein subunit gamma‐12 (GNG12) belongs to the G protein...
Main Authors: | Juan Li, Can Jin, Chuanxin Zou, Xu Qiao, Peng Ma, Di Hu, Wenqin Li, Jun Jin, Xin Jin, Ping Fan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-02-01
|
Series: | FEBS Open Bio |
Subjects: | |
Online Access: | https://doi.org/10.1002/2211-5463.12784 |
Similar Items
-
Mechanisms Governing Immunotherapy Resistance in Pancreatic Ductal Adenocarcinoma
by: Zoe C. Schmiechen, et al.
Published: (2021-01-01) -
A PD-L2-based immune marker signature helps to predict survival in resected pancreatic ductal adenocarcinoma
by: Yiyin Zhang, et al.
Published: (2019-08-01) -
Aberrant downstream mechanisms following depletion of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma
by: Dawkins, Joshua Benjamin Newton
Published: (2017) -
Metastatic pancreatic ductal adenocarcinoma in a teenage girl: A rare disease
by: Sutaryo Sutaryo, et al.
Published: (2020-11-01) -
Disparities in Pancreatic Ductal Adenocarcinoma—The Significance of Hispanic Ethnicity, Subgroup Analysis, and Treatment Facility on Clinical Outcomes
by: Andrea N. Riner, et al.
Published: (2020-06-01)